AAAAAA
Results: 1-25/96
Authors:
BALLOW CH
AMSDEN GW
HIGHET VS
FORREST A
Citation: Ch. Ballow et al., PHARMACOKINETICS OF ORAL AZITHROMYCIN IN SERUM, URINE, POLYMORPHONUCLEAR LEUKOCYTES AND INFLAMMATORY VS NONINFLAMMATORY SKIN BLISTERS IN HEALTHY-VOLUNTEERS, Clinical drug investigation, 15(2), 1998, pp. 159-167
Authors:
SCHENTAG JJ
STRENKOSKINIX LC
NIX DE
FORREST A
Citation: Jj. Schentag et al., PHARMACODYNAMIC INTERACTIONS OF ANTIBIOTICS ALONE AND IN COMBINATION, Clinical infectious diseases, 27(1), 1998, pp. 40-46
Authors:
FORREST A
Citation: A. Forrest, A DICTIONARY OF THE RURAL WORLD - WORDS FROM THE PAST - FRENCH - LACHIVER,M, TLS. Times literary supplement, (4985), 1998, pp. 12-12
Authors:
PISCITELLI SC
VOGEL S
FIGG WD
RAJE S
FORREST A
METCALF JA
BASELER M
FALLOON J
Citation: Sc. Piscitelli et al., ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Pharmacotherapy, 18(6), 1998, pp. 1212-1216
Authors:
ALLEN K
GOLDEN LH
CHING MI
FORREST A
NILES C
NISWANDER P
BARLOW J
IZZO JI
Citation: K. Allen et al., NORMALIZATION OF HYPERTENSIVE RESPONSES DURING AMBULATORY SURGICAL STRESS BY PERIOPERATIVE MUSIC, Journal of hypertension, 16, 1998, pp. 27035-27035
Authors:
LACKIE CL
LUZIER AB
DONOVAN JA
FERAS HI
FORREST A
Citation: Cl. Lackie et al., WEIGHT-BASED HEPARIN DOSING - CLINICAL-RESPONSE AND RESOURCE UTILIZATION, Clinical therapeutics, 20(4), 1998, pp. 699-710
Authors:
KAZIERAD DJ
MARTIN DE
ILSON B
BOIKE S
ZARIFFA N
FORREST A
JORKASKY DK
Citation: Dj. Kazierad et al., EPROSARTAN DOES NOT AFFECT THE PHARMACODYNAMICS OF WARFARIN, Journal of clinical pharmacology, 38(7), 1998, pp. 649-653
Authors:
CHING MI
SUNG BH
FORREST A
WILSON MF
IZZO JL
Citation: Mi. Ching et al., VASOREACTIVITY IN PRE-MENOPAUSAL AND POSTMENOPAUSAL WOMEN - EVALUATION BY PHARMACODYNAMIC MODELING, Journal of clinical pharmacology, 38(2), 1998, pp. 151-159
Authors:
STRENKOSKINIX LC
FORREST A
SCHENTAG JJ
NIX DE
Citation: Lc. Strenkoskinix et al., PHARMACODYNAMIC INTERACTIONS OF CIPROFLOXACIN, PIPERACILLIN, AND PIPERACILLIN TAZOBACTAM IN HEALTHY-VOLUNTEERS/, Journal of clinical pharmacology, 38(11), 1998, pp. 1063-1071
Authors:
THOMAS JK
FORREST A
BHAVNANI SM
HYATT JM
CHENG A
BALLOW CH
SCHENTAG JJ
Citation: Jk. Thomas et al., PHARMACODYNAMIC EVALUATION OF FACTORS ASSOCIATED WITH THE DEVELOPMENTOF BACTERIAL-RESISTANCE IN ACUTELY ILL PATIENTS DURING THERAPY, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 521-527
Authors:
FORREST A
Citation: A. Forrest, THE OXFORD ILLUSTRATED HISTORY OF MODERN EUROPE - BLANNING,TCW, History, 83(269), 1998, pp. 178-178
Authors:
FORREST A
Citation: A. Forrest, MEMOIRS OF SERGEANT BOURGOGNE, 1812-1813 - PARTRIDGE,R, History, 83(269), 1998, pp. 187-187
Authors:
PISCITELLI SC
FORREST A
VOGEL S
CHAITT D
METCALF J
STEVENS R
BASELER M
DAVEY RT
KOVACS JA
Citation: Sc. Piscitelli et al., PHARMACOKINETIC MODELING OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 492-498
Authors:
MAYO K
FONG D
FORREST A
PALADINO J
Citation: K. Mayo et al., A COMPARISON OF STATISTICAL-METHODS FOR PHARMACOECONOMIC ANALYSIS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 95-95
Authors:
HYATT JM
FORREST A
FEURSTEIN S
SCHENTAG JJ
Citation: Jm. Hyatt et al., PHARMACOMETRIC MODELING OF RISK-FACTORS FOR CIPROFLOXACIN RESISTANCE (CIP-R)IN PSEUDOMONAS-AERUGINOSA (PA), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 106-106
Authors:
HYATT JM
FORREST A
FEURSTEIN S
SCHENTAG JJ
Citation: Jm. Hyatt et al., PHARMACOMETRIC MODELING OF RISK-FACTORS FOR IMIPENEM RESISTANCE (IMI-R) IN PSEUDOMONAS-AERUGINOSA (PA), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 107-107
Authors:
FORREST A
KOVACS SJ
TSE EG
MARTIN DE
KAZIERAD DJ
Citation: A. Forrest et al., A NOVEL PK PD MODEL FOR WARFARIN (W) EMPLOYING DIRECT AND INDIRECT EFFECTS/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 109-109
Authors:
LUZIER AB
FORREST A
ADELMAN M
HAWARI FI
SCHENTAG JJ
IZZO JL
Citation: Ab. Luzier et al., IMPACT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR UNDERDOSING ON REHOSPITALIZATION RATES IN CONGESTIVE-HEART-FAILURE, The American journal of cardiology, 82(4), 1998, pp. 465-469
Authors:
AMSDEN GW
BALLOW CH
FORREST A
Citation: Gw. Amsden et al., COMPARISON OF THE PLASMA, URINE AND BLISTER FLUID PHARMACOKINETICS OFCLARITHROMYCIN AND AZITHROMYCIN IN NORMAL SUBJECTS, Clinical drug investigation, 13(3), 1997, pp. 152-161
Authors:
BURSTEIN AH
GAL P
FORREST A
Citation: Ah. Burstein et al., EVALUATION OF A SPARSE SAMPLING STRATEGY FOR DETERMINING VANCOMYCIN PHARMACOKINETICS IN PRETERM NEONATES - APPLICATION OF OPTIMAL SAMPLING THEORY, The Annals of pharmacotherapy, 31(9), 1997, pp. 980-983
Authors:
SAIGAL N
VENUTO R
TORNATORE K
GAREY K
MURRAY B
FORREST A
INGALLS E
DIFRANCESCO R
REED K
MORSE G
Citation: N. Saigal et al., GANCICLOVIR (G) PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS (RTR) WITH CYTOMEGALOVIRUS (CMV) INFECTION, Journal of the American Society of Nephrology, 8, 1997, pp. 3263-3263
Authors:
FORREST A
Citation: A. Forrest, THE TRUTH IS OUT THERE, BMJ. British medical journal, 315(7122), 1997, pp. 1629-1630
Authors:
FORREST A
Citation: A. Forrest, VENALITY - THE SALE OF OFFICES IN 18TH-CENTURY FRANCE - DOYLE,W, TLS. Times literary supplement, (4911), 1997, pp. 28-28
Authors:
FORREST A
CHODOSH S
AMANTEA MA
COLLINS DA
SCHENTAG JJ
Citation: A. Forrest et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL GREPAFLOXACIN IN PATIENTS WITH ACUTE BACTERIAL EXACERBATIONS OF CHRONIC-BRONCHITIS, Journal of antimicrobial chemotherapy, 40, 1997, pp. 45-57
Authors:
PISCITELLI SC
FORREST A
LUSH RM
RYAN N
WHITFIELD LR
FIGG WD
Citation: Sc. Piscitelli et al., PHARMACOMETRIC ANALYSIS OF THE EFFECT OF FUROSEMIDE ON SURAMIN PHARMACOKINETICS, Pharmacotherapy, 17(3), 1997, pp. 431-437